Related Experiment Videos

Is N-methyl-N'-nitro-N-nitrosoguanidine a hormonal carcinogen? (Review)

M Kodama1, T Kodama, M Kodama

  • 1Kodama Research Institute of Preventive Medicine, Nagoya, Japan.

Anticancer Research
|March 1, 1991
PubMed

Insights

N-methyl-N-nitro-N-nitrosoguanidine (MNNG), a carcinogen, may mimic steroid hormones. This interaction with hormone receptors could play a role in its carcinogenic effects on the gastric epithelium.

Area of Science:

  • Endocrinology
  • Carcinogenesis
  • Molecular Biology

Background:

  • N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) is a known carcinogen.
  • The role of hormonal signaling in carcinogenesis is an area of active research.

Purpose of the Study:

  • To investigate the hormonal mechanisms underlying the carcinogenic potency of MNNG on gastric epithelium.
  • To explore the potential steroid-mimetic properties of MNNG.

Main Methods:

  • Assessing MNNG's affinity for mouse glucocorticoid and androgen receptors.
  • Evaluating MNNG's effects on hydrocortisone and dihydrotestosterone turnover in mouse gastric tissue.
  • Measuring MNNG's induction of ornithine decarboxylase.
  • Examining MNNG's interference with hydrocortisone-mediated water turnover.

Main Results:

  • MNNG exhibits affinities for glucocorticoid and androgen receptors.
  • MNNG influences the turnover of hydrocortisone and dihydrotestosterone.
  • MNNG induces ornithine decarboxylase in gastric tissue.
  • MNNG interferes with hydrocortisone-linked water turnover, suggesting steroid-mimetic activity.

Conclusions:

  • MNNG displays steroid-mimetic properties, potentially acting as an androgen antagonist and a mixed glucocorticoid agonist/antagonist.
  • Chemical carcinogens may interact with the steroid hormone receptor superfamily in cancer induction.
  • Further research into steroid receptor biology is crucial for understanding MNNG's carcinogenesis.

Related Concept Videos